SCHEMBL7842844

SCHEMBL7842844

Oc1c(Br)cc(-c2ccccc2)cc1Br

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 2/20 1.00
CRHR2 Q13324 2/20 1.00
AKR1C2 P52895 4/20 0.68
AKR1C1 Q04828 4/20 0.68
AKR1C3 P42330 2/20 0.68
AKR1C4 P17516 1/20 0.68
CYP3A4 P08684 1/20 0.48
TSHR P16473 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
PTPN1 P18031 3/20 0.46
ALDH1A1 P00352 4/20 0.46
MAPK1 P28482 3/20 0.46
MMP3 P08254 1/20 0.46
BCL2L1 Q07817 1/20 0.46
ALOX5 P09917 1/20 0.44
TTR P02766 1/20 0.44
BACE1 P56817 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21345872 0.87 CRHBP (0.76) CRHBPCRHR2AKR1C2AKR1C1AKR1C3
SCHEMBL581997 0.84 CRHBP (0.70) CRHBPCRHR2AKR1C2AKR1C1AKR1C3
SCHEMBL18319714 0.82 AKR1C2 (1.00) CRHBPCRHR2AKR1C2AKR1C1AKR1C3
SCHEMBL11778374 0.82 CRHBP (0.68) CRHBPCRHR2AKR1C2AKR1C1AKR1C3
SCHEMBL9512827 0.80 CRHBP (0.66) CRHBPCRHR2AKR1C2AKR1C1AKR1C3
SCHEMBL6346254 0.80 CRHBP (0.66) CRHBPCRHR2AKR1C2AKR1C1AKR1C3
SCHEMBL7334496 0.80 CRHBP (0.67) CRHBPCRHR2AKR1C2AKR1C1AKR1C3
SCHEMBL29662848 0.79 APEX1 (0.67) CRHBPCRHR2AKR1C2AKR1C1AKR1C3
SCHEMBL5306730 0.79 AKR1C2 (0.75) CRHBPCRHR2AKR1C2AKR1C1AKR1C3
SCHEMBL22717286 0.77 CRHBP (0.62) CRHBPCRHR2AKR1C2AKR1C1AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11197854-B1 Inhibitors for targeting flaviviruses NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) 2021-12-14 US disclosed
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 US disclosed
WO-2018204764-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION (US) 2018-11-08 WO disclosed
EP-1077967-A2 BIPHENYL OXO-ACETIC ACIDS USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA AMERICAN HOME PRODUCTS CORPORATION (US) 2001-02-28 EP disclosed
WO-1999058518-A2 BIPHENYL OXO-ACETIC ACIDS USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA AMERICAN HOME PRODUCTS CORPORATION (US) 1999-11-18 WO disclosed
US-4170614-A HYDROLYSIS OF TRIS(2,6-DIHALOPHENYL) PHOSPHATE PPG INDUSTRIES, INC. (US) 1979-10-09 US disclosed
US-4059655-A REACTING A 2,6-DIHALOPHENOL WITH PHOSPHORUS OXYHALIDE, HYDROLYSIS PPG INDUSTRIES, INC. (US) 1977-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11197854-B1 Inhibitors for targeting flaviviruses HAVCR2, MME, SPINT2 CRHBP 1000/4885CRHR2 4705/4885AKR1C2 4678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.